Background: In response to a mumps outbreak at the University of Iowa and surrounding community, university, state, and local health officials implemented a vaccination campaign targeting students <25 years of age with an additional dose of measles-mumps-rubella (MMR) vaccine. More than 4700 vaccine campaign doses were administered; 97% were documented third doses. We describe the epidemiology of the outbreak before and after the campaign, focusing on cases in university students. Methods: Mumps cases were identified from reportable disease databases and university health system records. Detailed information on student cases was obtained from interviews, medical chart abstractions, university and state vaccination records, and state public health laboratory results. Pre- and postcampaign incidence among students, university faculty/staff, and community members <25 vs ≥25 years old were compared using Fisher exact test. Multivariable regression modeling was performed to identify variables associated with a positive mumps polymerase chain reaction test. Results: Of 453 cases in the county, 301 (66%) occurred in university students. Student cases were primarily undergraduates (90%) and highly vaccinated (86% had 2 MMR doses, and 12% had 3 MMR doses). Fewer cases occurred in students after the campaign (75 [25%]) than before (226 [75%]). Cases in the target group (students <25 years of age) declined 9% postcampaign (P=.01). A positive mumps polymerase chain reaction test was associated with the presence of parotitis and early sample collection, and inversely associated with recent receipt of MMR vaccine. Conclusions: Following a large additional dose MMR vaccination campaign, fewer mumps cases occurred overall and in the target population. Published by Oxford University Press for the Infectious Diseases Society of America 2017. This work is written by (a) US Government employee(s) and is in the public domain in the US.
Background: In response to a mumps outbreak at the University of Iowa and surrounding community, university, state, and local health officials implemented a vaccination campaign targeting students <25 years of age with an additional dose of measles-mumps-rubella (MMR) vaccine. More than 4700 vaccine campaign doses were administered; 97% were documented third doses. We describe the epidemiology of the outbreak before and after the campaign, focusing on cases in university students. Methods: Mumps cases were identified from reportable disease databases and university health system records. Detailed information on student cases was obtained from interviews, medical chart abstractions, university and state vaccination records, and state public health laboratory results. Pre- and postcampaign incidence among students, university faculty/staff, and community members <25 vs ≥25 years old were compared using Fisher exact test. Multivariable regression modeling was performed to identify variables associated with a positive mumps polymerase chain reaction test. Results: Of 453 cases in the county, 301 (66%) occurred in university students. Student cases were primarily undergraduates (90%) and highly vaccinated (86% had 2 MMR doses, and 12% had 3 MMR doses). Fewer cases occurred in students after the campaign (75 [25%]) than before (226 [75%]). Cases in the target group (students <25 years of age) declined 9% postcampaign (P=.01). A positive mumps polymerase chain reaction test was associated with the presence of parotitis and early sample collection, and inversely associated with recent receipt of MMR vaccine. Conclusions: Following a large additional dose MMR vaccination campaign, fewer mumps cases occurred overall and in the target population. Published by Oxford University Press for the Infectious Diseases Society of America 2017. This work is written by (a) US Government employee(s) and is in the public domain in the US.
Authors: Cristina V Cardemil; Rebecca M Dahl; Lisa James; Kathleen Wannemuehler; Howard E Gary; Minesh Shah; Mona Marin; Jacob Riley; Daniel R Feikin; Manisha Patel; Patricia Quinlisk Journal: N Engl J Med Date: 2017-09-07 Impact factor: 91.245
Authors: Li Jin; Claes Örvell; Richard Myers; Paul A Rota; Tetsuo Nakayama; Dubravko Forcic; Joanne Hiebert; Kevin E Brown Journal: Rev Med Virol Date: 2014-11-26 Impact factor: 6.989
Authors: Jennifer S Rota; Jennifer B Rosen; Margaret K Doll; Rebecca J McNall; Marcia McGrew; Nobia Williams; Elena N Lopareva; Albert E Barskey; Amado Punsalang; Paul A Rota; William R Oleszko; Carole J Hickman; Christopher M Zimmerman; William J Bellini Journal: Clin Vaccine Immunol Date: 2013-01-16
Authors: Sigrid Gouma; Susan J M Hahné; Daphne B Gijselaar; Marion P G Koopmans; Rob S van Binnendijk Journal: Vaccine Date: 2016-03-05 Impact factor: 3.641
Authors: Ikechukwu U Ogbuanu; Preeta K Kutty; Jean M Hudson; Debra Blog; Glen R Abedi; Stephen Goodell; Jacqueline Lawler; Huong Q McLean; Lynn Pollock; Elizabeth Rausch-Phung; Cynthia Schulte; Barbara Valure; Gregory L Armstrong; Kathleen Gallagher Journal: Pediatrics Date: 2012-11-05 Impact factor: 7.124
Authors: Albert E Barskey; Cynthia Schulte; Jennifer B Rosen; Elizabeth F Handschur; Elizabeth Rausch-Phung; Margaret K Doll; Kisha P Cummings; E Oscar Alleyne; Patricia High; Jacqueline Lawler; Andria Apostolou; Debra Blog; Christopher M Zimmerman; Barbara Montana; Rafael Harpaz; Carole J Hickman; Paul A Rota; Jennifer S Rota; William J Bellini; Kathleen M Gallagher Journal: N Engl J Med Date: 2012-11-01 Impact factor: 91.245
Authors: Kelsey Briggs; Cara Kirby; Ashley C Beavis; James Zengel; Preetish Patil; Christian Sauder; Biao He Journal: J Virol Date: 2022-04-07 Impact factor: 6.549
Authors: Mona Marin; Tricia L Kitzmann; Lisa James; Patricia Quinlisk; Wade K Aldous; John Zhang; Cristina V Cardemil; Chris Galeazzi; Manisha Patel; Ismael R Ortega-Sanchez Journal: Open Forum Infect Dis Date: 2018-10-04 Impact factor: 3.835